OpenEvidence hits $12B valuation, with new round led by Thrive, DST

Market Intelligence Analysis

AI-Powered
Why This Matters

OpenEvidence, a medical information database, has reached a $12 billion valuation after a new funding round led by Thrive and DST, doubling its valuation since October. This achievement comes despite competition from model makers in the industry. The company's growth suggests a strong demand for its services.

Market Impact

Market impact analysis based on bullish sentiment with 90% confidence.

Sentiment
Bullish
AI Confidence
90%
Time Horizon
Short Term

Article Context

Note: This is a brief excerpt for context. Click below to read the full article on the original source.

The medical info database has doubled in valuation since last raise in October, despite encroachment from model makers.

Continue Reading
Full article on TechCrunch
Read Full Article
Original article published by TechCrunch on January 21, 2026.
Analysis and insights provided by AnalystMarkets AI.